Related Experiment Video

Updated: May 24, 2026

Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
06:04

Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex

Published on: July 4, 2018

Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit

Palmer G Johnston1, Maria Gillam-Krakauer, M Paige Fuller

  • 1Neonatal-Perinatal Medicine, Division of Neonatology, Department of Pediatrics, Vanderbilt University Medical Center, 2200 Children's Way, Nashville, TN 37232-9544, USA.

Clinics in Perinatology
|February 21, 2012
PubMed

Insights

Indomethacin and ibuprofen are crucial for preventing intraventricular hemorrhage (IVH) and patent ductus arteriosus (PDA) in neonates. Despite calls for caution, these drugs remain vital for the most vulnerable infants to ensure optimal outcomes.

Area of Science:

  • Neonatal pharmacology
  • Pediatric intensive care
  • Prostaglandin inhibition

Background:

  • Indomethacin and ibuprofen inhibit prostaglandin synthesis.
  • Neonates have been treated with these drugs for over 30 years.
  • Common uses include preventing intraventricular hemorrhage (IVH) and treating patent ductus arteriosus (PDA).

Purpose of the Study:

  • To review the scientific basis for using indomethacin and ibuprofen in neonatal intensive care.
  • To evaluate the role of these drugs in managing IVH and PDA in neonates.

Main Methods:

  • Literature review of studies on indomethacin and ibuprofen in neonates.
  • Analysis of clinical data regarding the efficacy and safety of these drugs.
  • Examination of the physiological rationale for their use.

Main Results:

  • Indomethacin is frequently used to prevent high-grade IVH.
  • Both indomethacin and ibuprofen are used for the treatment or prevention of PDA.
  • Pharmacologic interventions are often necessary for the most immature infants.

Conclusions:

  • Despite recommendations for judicious use, indomethacin and ibuprofen remain essential pharmacologic tools in neonatal intensive care.
  • These medications play a critical role in reducing IVH and managing PDA, contributing to better outcomes for premature infants.
  • The benefits of these drugs in specific neonatal populations outweigh the risks, particularly for the most vulnerable infants.

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Nursing Clinical Information System01:27

Nursing Clinical Information System

Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...